Does NILOTINIB Cause Neoplasm malignant? 125 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 125 reports of Neoplasm malignant have been filed in association with NILOTINIB (nilotinib). This represents 0.5% of all adverse event reports for NILOTINIB.
125
Reports of Neoplasm malignant with NILOTINIB
0.5%
of all NILOTINIB reports
12
Deaths
19
Hospitalizations
How Dangerous Is Neoplasm malignant From NILOTINIB?
Of the 125 reports, 12 (9.6%) resulted in death, 19 (15.2%) required hospitalization, and 7 (5.6%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NILOTINIB. However, 125 reports have been filed with the FAERS database.
What Other Side Effects Does NILOTINIB Cause?
Death (2,667)
Fatigue (1,679)
Rash (1,250)
Nausea (1,180)
Headache (1,177)
Pain (1,169)
Dyspnoea (1,070)
Diarrhoea (998)
Drug ineffective (992)
Malaise (961)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which NILOTINIB Alternatives Have Lower Neoplasm malignant Risk?
NILOTINIB vs NIMESULIDE
NILOTINIB vs NIMODIPINE
NILOTINIB vs NINTEDANIB
NILOTINIB vs NINTEDANIB ESYLATE
NILOTINIB vs NIRAPARIB